Low-dose imatinib therapy leads to rapid induction of major molecular responses with achievement of molecular remission in FIP1L1 -PDGFRA associated hypereosinophilic syndrome


Jovanovic, J., Score, J., Waghorn, K., Reiter, A., Gottardi, E., Saglio, G., Apperley, J., Martinelli, G., Preudhomme, C., Hehlmann, R., Grimwade, D. and Cross, N.C.P. (2006) Low-dose imatinib therapy leads to rapid induction of major molecular responses with achievement of molecular remission in FIP1L1 -PDGFRA associated hypereosinophilic syndrome. British Journal of Haematology, 133, (s1), p.13. (doi:10.1111/j.1365-2141.2006.06027.x).

Download

Full text not available from this repository.

Item Type: Article
ISSNs: 0007-1048 (print)
Related URLs:
Keywords: publishing, england, imatinib, hypereosinophilic syndrome, germany, france, london, syndrome, italy, therapy, time
Subjects: R Medicine > RC Internal medicine
Q Science > QH Natural history > QH426 Genetics
Divisions: University Structure - Pre August 2011 > School of Medicine > Human Genetics
ePrint ID: 59897
Date Deposited: 17 Nov 2008
Last Modified: 27 Mar 2014 18:42
URI: http://eprints.soton.ac.uk/id/eprint/59897

Actions (login required)

View Item View Item